Mirum Pharmaceuticals (MIRM) Retained Earnings: 2020-2025
Historic Retained Earnings for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to -$661.8 million.
- Mirum Pharmaceuticals' Retained Earnings fell 6.68% to -$661.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$661.8 million, marking a year-over-year decrease of 6.68%. This contributed to the annual value of -$644.2 million for FY2024, which is 15.81% down from last year.
- According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Retained Earnings is -$661.8 million, which was up 0.44% from -$664.7 million recorded in Q2 2025.
- Over the past 5 years, Mirum Pharmaceuticals' Retained Earnings peaked at -$223.7 million during Q1 2021, and registered a low of -$664.7 million during Q2 2025.
- Over the past 3 years, Mirum Pharmaceuticals' median Retained Earnings value was -$606.2 million (recorded in 2024), while the average stood at -$585.0 million.
- Data for Mirum Pharmaceuticals' Retained Earnings shows a maximum YoY tumbled of 145.26% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Retained Earnings stood at -$257.2 million in 2021, then tumbled by 52.76% to -$392.8 million in 2022, then plummeted by 41.60% to -$556.2 million in 2023, then declined by 15.81% to -$644.2 million in 2024, then decreased by 6.68% to -$661.8 million in 2025.
- Its Retained Earnings was -$661.8 million in Q3 2025, compared to -$664.7 million in Q2 2025 and -$658.9 million in Q1 2025.